Related references
Note: Only part of the references are listed.Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net
Petra Steinacker et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)
Serum neurofilament is associated with progression of brain atrophy and disability in early MS
Jens Kuhle et al.
NEUROLOGY (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
Jens Kuhle et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
Jonathan D. Rohrer et al.
NEUROLOGY (2016)
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
Pashtun Shahim et al.
SCIENTIFIC REPORTS (2016)
Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection
Christopher Traenka et al.
CEREBROVASCULAR DISEASES (2015)
Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study
Ching-Hua Lu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
Jens Kuhle et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: The CoRisk Study
Gian Marco De Marchis et al.
INTERNATIONAL JOURNAL OF STROKE (2013)
Copeptin adds prognostic information after ischemic stroke Results from the CoRisk study
Gian Marco De Marchis et al.
NEUROLOGY (2013)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke
P. Singh et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Hyperacute Detection of Neurofilament Heavy Chain in Serum Following Stroke: A Transient Sign
Johann Sellner et al.
NEUROCHEMICAL RESEARCH (2011)
Copeptin: A Novel, Independent Prognostic Marker in Patients with Ischemic Stroke
Mira Katan et al.
ANNALS OF NEUROLOGY (2009)
ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes
J. R. Sims et al.
NEUROLOGY (2009)
Definition and Evaluation of Transient Ischemic Attack A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.
J. Donald Easton et al.
STROKE (2009)